Now showing items 1-2 of 2
Assessment of radioiodine clearance in patients with differentiated thyroid cancer
Radioiodine (131I iodide) has long been a safe, effective and widely used treatment in the management of differentiated thyroid cancer (DTC). Concerns regarding stochastic radiogenic risks have led to regulatory criteria ...
Chromosome aberrations after high-dose 131I and 99mTc-MIBI administration using a micronucleus assay
Objective: We evaluated the potential detrimental cytogenetic effects of 99mTc-methoxyisobutyl isonitrile (MIBI) and 131I on patients who were exposed to the radiopharmaceutics for cardiac imaging or thyroid cancer therapy, ...